Publications by authors named "Simon Daenen"

Claim this Profile
M
Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
Petros Pechlivanoglou, Hoa H Le, Simon Daenen, John A Snowden, Maarten J Postma

J Antimicrob Chemother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.
Arnon P Kater, Marjolein Spiering, Roberto D Liu, G Doreen Te Raa, E Slinger, Simon Daenen

Leuk Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).
Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, Gregor E G Verhoef, Titia Gussinklo, Simon M G Daenen

Eur J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients.
Lieke H van der Helm, Ellen R M Scheepers, Nic J G M Veeger, Simon M G J Daenen, André B Mulder

J Hematol Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.
Petros Pechlivanoglou, Robin De Vries, Simon M G J Daenen, Maarten J Postma

Pharmacoeconomics· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
Szabolcs Fatrai, Albertus T J Wierenga, Simon M G J Daenen, Edo Vellenga, Jan Jacob Schuringa

Blood· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways.
Szabolcs Fatrai, Djoke van Gosliga, Lina Han, Simon M G J Daenen, Edo Vellenga

J Biol Chem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.
Wendy Deenik, Jeroen J W M Janssen, Bronno van der Holt, Gregor E G Verhoef, Willem M Smit, Simon M G J Daenen

Haematologica· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens.
Jan W M van der Linden, Eveline Snelders, Jan P Arends, Simon M Daenen, Willem J G Melchers

J Clin Microbiol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
Jan-Willem C Alffenaar, Kim C M van der Elst, Donald R A Uges, Jos G W Kosterink, Simon M G J Daenen

Br J Clin Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
Yvonne H Tromp, Simon M G J Daenen, Wim J Sluiter, Edo Vellenga

Eur J Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?
Jan-Willem C Alffenaar, Tessa de Vos, Donald R A Uges, Simon M G J Daenen

Br J Clin Pharmacol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
Szabolcs Fatrai, Hein Schepers, Henko Tadema, Edo Vellenga, Simon M G J Daenen

Exp Hematol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
Robin de Vries, Simon Daenen, Keith Tolley, Axel Glasmacher, Archie Prentice

Pharmacoeconomics· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved flow cytometric method using FACS Lysing Solution for measurement of ZAP-70 expression in B-cell chronic lymphocytic leukemia.
Roelof Bekkema, Afke Tadema, Simon M G J Daenen, Hanneke C Kluin-Nelemans, André B Mulder

Cytometry B Clin Cytom· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.
Jan J Meeuse, Herman G Sprenger, Sander van Assen, Dominique Leduc, Simon M G J Daenen

Emerg Infect Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.
Simon Daenen, Gustaaf W van Imhoff, Joost T M de Wolf, Edo Vellenga, Eva van den Berg-de Ruiter

Br J Haematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J Cornelissen, Wim L J van Putten, Leo F Verdonck, Matthias Theobald, Emanuel Jacky, Simon M G Daenen

Blood· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
Francis Giles, David Rizzieri, Judith Karp, Norbert Vey, Farhad Ravandi, Simon M G J Daenen

J Clin Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia.
Francis Giles, Srdan Verstovsek, Stefan Faderl, Norbert Vey, Judy Karp, Simon Daenen

Leuk Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report.
Sandra Scm Loves, Lieuwe de Haan, Simon Mgj Daenen

Hered Cancer Clin Pract· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
Sabine L A Plasschaert, Eveline S J M de Bont, Marike Boezen, Dorina M vander Kolk, Simon M J G Daenen

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Claudi Oude Nijhuis, Willem A Kamps, Simon M G Daenen, Jourik A Gietema, Winette T A van der Graaf

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study.
Sjoerd Hovenga, Simon M G J Daenen, Joost T M de Wolf, Gustaaf W van Imhoff, Hanneke C Kluin-Nelemans

Ann Hematol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cells.
Kyrjon van Pelt, Gerald de Haan, Edo Vellenga, Simon M G J Daenen

Exp Hematol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis